3

FORM 3 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: July 15, 2021
Period of Report: July 14, 2021
Accession Number: 0000899243-21-028493

View Document ↗ View on SEC.gov ↗